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Know then thyself, presume not God to scan; 
The proper study of Mankind is Man . . . .  
Sole judge of truth, in endless Error hurled, 
The glory, jest and riddle of the world! 
Alexander Pope, An Essay on Man, i733 
It may come as a surprise to some that the 
programs of The Society for Vascular Surgery were 
not always as exciting and timely as they have become 
again these past fewyears. At the time of the founding 
of the Society, vascular surgery was concentrated in 
medical centers. Members were highly interactive. 
New discoveries and new applications came in rapid 
succession. Most of us had access to a surgical research 
laboratory, a dog, and a research-minded resident, 
and we had time to perform research ourselves. Funds 
were available. Our members turned their attention to 
improving radiopaque contrast media, arterial grafts, 
noninvasive imaging assessment of occlusive arterial 
disease, and perfection of operative approaches. Re- 
fmement of indications for revascularization proce- 
dures, identification ofoperative risk, and standard- 
ization of reporting of degrees of disease and of 
complications of treatment made up the bulk of the 
papers elected for the program of the annual meet- 
ings. Space on the program was limited and very 
competitive. Each annual meeting was a rich intellec- 
tual experience. It was a stimulating time to enter this 
nascent specialty. The flood of new ideas and proce- 
dures, however, gradually slowed and became a 
trickle. Programs consisted of papers extending the 
number of patients in a clinical series and other 
developments of marginal significance. Very little 
research was directed to new and fimdamental discov- 
eries. Rene Leriche had identified the problem several 
decades earlier: "the problem with surgery is the 
problem of lack of knowledge." 
The repetitive clinical content of the Society's 
programs prompted one prominent member to liken 
them to reshuffling a lot of old bones. Clinical case 
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studies were not the only old bones being reshuffled 
in these middle years; so were the members. With the 
membership limited by numbers and, except for the 
founding fathers, most of us being within a few years 
of age of each other, the membership was rapidly 
growing older. Inductions of young members were 
infrequent, and the attendance ofyoung people was 
limited by Society rules and by an individual's fund- 
ing. Some of us feared that in another 10 years the 
Society would become a riving archive; its meetings 
not unlike a gathering of alumni. Partial restitution 
came with a revision of the criteria for membership in 
the North American Chapter of the International 
Society for Cardiovascular Surgery. Restrictions were 
relaxed; the membership ceiling was increased; 
younger entry-level vascular surgeons were encour- 
aged to attend. All of this was constitutionally per- 
missible by emphasizing the educational opportunity 
presented by the Society and the responsibility ofthe 
members to improve the quality of vascular surgery 
practice in the community. The Society for Vascular 
Surgery benefited from the back-to-back meetings of 
the two groups. 
Resurgence of innovation and interest came with 
the emergence ofsophisticated imaging technologies 
that reduced the need for angiography, once the Holy 
Grail of vascular surgery; deliberate penetration fthe 
arterial lumen, once an anathema tothe high priests of 
vascular surgery; endoscopes, stents, and other thera- 
peutic and diagnostic devices; and the evolution of 
meaningful treatment for long-neglected venous dis- 
ease. All breathed new life into our discipline. The 
intellectual content of our meetings improved. 
Still, present and future problems remained. 
There was a striking lack of understanding of the 
importance ofinduction of younger members into the 
Society, of its collateral problem of lack of a mecha- 
nism whereby ounger candidates could obtain an 
audience for their work and eventually be invited to 
membership, and of the paucity of meaningful re- 
search being presented to the members of Society. 
"Meaningful research" requires definition. 
In the early years of the Society, virtually every 
member could claim the tide of research for his 
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presentations. That it would not be so designated by 
more learned societies uch as the natural sciences was 
of little concern. The programs abounded in reports 
of new discoveries. Almost exclusively these con- 
cerned technologic advances. They were of an obser- 
vational nature, with little sophisticated attempt to 
understand the biologic mechanisms underlying 
them. They were not basic research. Experimental 
design was dictated by recognition of a clinical need: 
better synthetic material, radiopaque contrast me- 
dium, antibiotics, and anticoagulants. In the case of 
synthetic arterial grafts, the experimental method was 
one of trial and error. Porosity, platelet activation, and 
nonthrombogenicity were of great concern, but their 
study was limited to observing the extent to which it 
was present or occurred. Little insight into the reasons 
for or causes of phenomena was achieved. This 
approach continues today, as illustrated by the effort 
exerted to prevent intimal hyperplasia and restenosis. 
The formal training and accumulated xperience 
of years of clinical practice had not prepared the 
leadership of vascular surgery for the challenges that 
became a part of their specialty. As the technologic 
advances of endarterectomy and bypass grafting 
solved the short-term problems of severe and symp- 
tomatic arterial occlusions, the long-term problems of 
progressive atherosclerosis and intimal hyperplasia 
were revealed. These problems were of a different 
order in that they did not yield to continuing tech- 
nologic improvements. Vascular surgery was believed 
to consist of a number of techniques, essentially 
mechanical in concept and execution, for relief of 
end-stage occlusive arterial disease. Our understand- 
ing of atherosclerosis as a systemic disease was super- 
ficial, and with pitifully few exceptions our research 
efforts in this area and in the biology of the arterial 
wall were negligible. 
The long-term problems defied solution. Small- 
caliber grafts, intimal hyperplasia, and progressive 
atherosclerosis singly and together defeated many 
revascularization attempts. 
Molecular vascular biology became introduced 
into the medical school curriculum and entered the 
clinical world via young graduates and vascular train- 
ees. Its potential for enabling investigation i to vas- 
cular problems was quickly appreciated, but its jargon 
and methods were foreign. The clinician had neither 
the time nor the apparent need to learn them. 
Fortunately, a few bright young investigators saw the 
opportunity for meaningful research. A sprinkling of 
what were labeled "basic science" papers began to 
appear on the programs. A basic research forum was 
implemented. Even poster sessions, perfectly accept- 
able to basic science symposia but disdained by some 
members, were introduced into our joint annual 
meeting. A confluence of disparate vents--techno- 
logically insoluble clinical problems; bright, young, 
ambitious investigators undaunted by the unfamiliar- 
ity with molecular biology; and an avenue by which 
young vascular trainees and surgeons could gain 
access to our meetings--combined to bring new 
intellectual vigor to our meetings. More and more 
young people actively participated in the meetings, 
and basic research found a more receptive audience. 
Endovascular concepts and techniques found hesitant 
but optimistic acceptance. The "old bones" of former 
meetings were set aside. A new vitality characterized 
The Society for Vascular Surgery. 
An essential ingredient was still missing. Funding 
for research became increasingly difficult o obtain. 
The largesse of the National Institutes of Health 
(NIH), so abundant for two or three decades after 
World War II, dropped continuously year by year as 
new national programs of presumed greater priority 
claimed tax dollars (Fig. 1). In terms of constant 
dollars, the high point was 1979. Even the higher 
projection for 1981 represents a decline in the pur- 
chasing power of 5.5%. 1'2 
The importance of devoting more national re- 
sources to vascular disease was explicitly stated in the 
1982 report of the Research Training and Develop- 
ment Task Group: "An important area that has been 
relatively neglected is that of peripheral vascular 
disease. More manpower is desirable to extend scien- 
tific and 'methodological advances to improve under- 
standing and control of peripheral vascular disease.'3 
The funding situation deteriorated more severely. In 
1973, 21% of the total research allotment of the NIH 
went to departments of internal medicine, compared 
with 13% received by departments of surgery. Ten 
years later, by 1982, surgery's share had decreased to
5.1%. Furthermore, it was noted that the ranks of 
medical researchers were being increasingly filled by 
scientists who were not medically trained (Fig. 2). The 
Heart and Blood Vessel Disease branch of the NIH 
awarded 212 traineeships and fellowships to holders 
of PhD degrees from 1972 to 1983, and holders of 
MD degrees received 630. From 1980 to 1982, PhD 
recipients numbered 358, compared with 291 for 
MD recipients. 
One need not have been clairvoyant during those 
years to recognize that financial support for research 
and the concurrent development ofyoung vascular 
surgeons would not be forthcoming from traditional 
sources. Federal funding could no longer be relied on. 
The burden would fall increasingly on individuals, 
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Fig. 1. Obligated funds for the aggregate of NIH pro- 
grams are shown for the ycars 1969 through 1980, with 
alternate projections for fiscal 1981. (From Fredrickson DS. 
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Fig. 2. Total number of NIH trainees and fellows declined 
from 18,945 in 1965 to an estimated 10,284 in 1980. 
During this period, total postdoctoral trainees, although 
declining in number, rose as a percentage of all trainees 
(from 48% to 55%). Physician postdoctoral researchers 
declined in both number and percentage (from 59% to 30%' 
of all postdoctoral researchers. 
departments, and societies who wished to engage m 
these activities. 
More recent experience demonstrates how grim 
the decline in N IH  funding has truly become. Figures 
released by the N IH for fiscal year 19935 revealed an 
overall actual success rate of only 9.2% for RO1 (type 
1 applications: new applications, unsolicited, un- 
amended, and competing). Continuing funding de- 
terioration over the past 10 years engenders the 
prediction that two out of three established investi- 
gators who submit renewal applications (type 2: 
renewal, competing) will not be funded. 4
The seed money once available from academic 
clinical departments has all but vanished under the 
yoke of competitive care. The offices of the dean, the 
hospital president, and the department chairman ow 
have ever more claims for financial support made 
against constantly dwindling dollars. The academic 
Lifeline Foundation 
Fig. 3. Logo of the Lifeline Foundation. 
community and The Society for Vascular Surgery 
were aware that funding was on a downward spiral and 
that we must depend more on our own resources. If
it was indeed important to the intellectual prosperity 
of the Society to provide an infusion of young blood, 
to investigate problems uch as intimal hyperplasia, 
and to move the conceptual basis of  vascular surgery 
from solely technologic problems to amore sophisti- 
cated intellectual level, intramural financial support 
must be generated. Happily, the treasury of the 
Society had accumulated a modest surplus. From this 
simple approach the Lifeline Foundation was created. 
It began during the discussion of  new business at the 
October 23, 1984, Council Meeting of the Society 
concerning "the utilization of certain assets of the 
Society to further the interests of younger surgeons in 
the specialty of vascular surgery." In the course of 2 
years, a consulting firm had made recommendations 
as to the nature and legal status of a tax-exempt 
foundation. At the Council Meeting of June 8, 1986, 
it was unanimously voted in two separate actions to 
"support the establishment of a foundation subject o 
further development ofa statement of purpose for the 
foundation," and "to contribute $50,000.00 from 
the Society's reserves for the formation of this Edu- 
cation and Research Foundation." Separately, "it was 
voted to appoint the current officers of the Society as 
Directors of the new Education and Research Foun- 
dation." The first meeting of the Board of Directors 
of the Foundation was held October 22, 1986, during 
the course of the Annual Congress of the American 
College of Surgeons. Officers elected were Calvin B. 
Ernst, President; Victor M. Bernard, Vice President; 
and Malcolm O. Perry, Secretary-Treasurer. 
A Mission Statement was written and rewritten. 
Its present version, adopted as amended April 7, 
1994, states: 
"The mission of the Lifeline Foundation is to 
support research and education i  vascular disease by: 
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• Enhancing the development of young surgical 
scientists and the advancement of vascular sci- 
ence through its comprehensive research fund- 
ing commitment. 
• Insuring that new knowledge concerning 
causes, treatment and prevention of  vascular 
disease isdisseminated tothe medical profession 
and the public." 
Alogo was designed by Dr. Calvin B. Ernst, and its 
use was made available to donors (Fig. 3) Provision 
was made for representation f  corporate donors on 
the Board of Directors. A request for research pro- 
posals was issued in 1991.s The judging process was 
formalized with establishment of a Research Com- 
mittee operating under guidelines based on the N IH  
Peer Review System. The North American Chapter of 
the International Society for Cardiovascular Surgery 
requested and was granted membership n the Foun- 
dation in 1994. In time the Lifeline Foundation 
assumed administrative r sponsibility for the E. J. 
Wylie Traveling Fellowship, the Student Research 
Stipend Program, the annual Research Initiatives 
Meeting, and the Resident Research Award. Recipi- 
ents of awards to date were, in 1992, Brian G. Rubin, 
MD, Washington University School of Medicine: 
"The Effect of Duration of Thrombosis on Vessel 
Wall Thrombogenicity;" in 1993, Colleen M. Bro- 
phy, MD, Medical College of Georgia Research 
Institute: "A  Molecular Model of Vasospasm;" in 
1994, Raymond G. Makhoul, MD, Medical College 
of Virginia: "L-arginine and Vascular Intimal 
Hyperplasia;" and in 1995, Michael A. Golden, MD, 
University of Pennsylvania Medical Center: "Gene 
Therapy for Control of  Vein Graft Intimal Hyper- 
plasia." 
The critical importance of the Lifeline Foundation 
is emphasized by the continuing reduction of research 
funds from the N IH  and from other sources that once 
were available from within academic enters. The 
threat o research and education endeavors continues 
to expand as managed care gains control. No volun- 
tary organization such as the Lifeline Foundation can 
meet more than a fraction of the needs of the research 
and academic ommunity. It was never intended that 
the Foundation could take the place of major funding 
sources. But, small as the dollar amounts are, it has 
made a difference to the present awardees. Small as 
the awards are, they may be just enough to keep alive 
the hope and the expectation of an academic areer. 
This need not be forever, but only until such time as 
reason returns to the practice of health care and the 
responsibility for it is rescued from disciples of the 
corporate balance sheet and returned to its rightful 
deacons: physicians and surgeons whose ideals of 
service subordinate profit. 
What keeps a society healthy, its members happy, 
its purpose effective? Why do we vascular surgeons 
seek our companionship once a year through an 
annual meeting pilgrimage and once a month 
through our journal? Alan Gregg 6cites three things 
mainly: shared experiences, beliefs generally agreed 
on, and hopes and desires held in common. Our 
companionship thus has elements of the past, the 
present, and the future. Heneage Ogilvie, 7 citing the 
benefits of travel by surgeons to professional meet- 
ings, holds that there is value for all who come: "your 
old men shall dream dreams and your young men shall 
dream visions." 
It is our hope that the Lifeline Foundation will 
assist materially in bringing these visions to reality, 
and that The Society for Vascular Surgery will 
prosper. 
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